Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHA:688621)

China flag China · Delayed Price · Currency is CNY
57.93
-0.63 (-1.08%)
Apr 30, 2026, 10:55 AM CST
26.02%
Market Cap 6.40B
Revenue (ttm) 1.19B
Net Income (ttm) 194.92M
Shares Out 109.28M
EPS (ttm) 1.76
PE Ratio 33.31
Forward PE n/a
Dividend 0.16 (0.28%)
Ex-Dividend Date n/a
Volume 1,291,552
Average Volume 2,469,122
Open 58.80
Previous Close 58.56
Day's Range 57.08 - 58.80
52-Week Range 41.91 - 86.50
Beta 0.13
RSI 34.64
Earnings Date Apr 24, 2026

About SHA:688621

Beijing Sun-Novo Pharmaceutical Research Co., Ltd., a contract research company, engages in the research and development of drugs in China. The company operates external preparation platform that focuses on the research and development of new drugs and generic drugs for skin external preparations; children's clinical data bridging research center; pediatric drug research and development platform; pediatric drug delivery dosage research and development platform; respiratory tract drug delivery and topical preparation platforms; polypeptide and o... [Read more]

Sector Healthcare
Founded 2009
Employees 1,359
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688621
Full Company Profile

Financial Performance

In 2025, SHA:688621's revenue was 1.22 billion, an increase of 13.33% compared to the previous year's 1.08 billion. Earnings were 203.87 million, an increase of 14.91%.

Financial Statements

News

There is no news available yet.